In vitro studies show synergistic effects of a procoagulant bispecific antibody and bypassing agents
| No. | 40 |
|---|---|
| Citation | J Thromb Haemost 16,p1580-1591(2018) |
| Institute | Shire |
| 1st Author | R Hartmann |
| AR | ○ |
| PL | |
| HD | |
| Paper types | Basic science |
| Main purpose | Drug efficacy evaluation |
| Disease | Hemophilia A |
| Antiplatelet drug | |
| Anticoagulant drug | |
| Other drug | emicizumab, aPCC, rFVIIa |
| Clinical specimens | |
| Animal | |
| Keyword | Bispecific antibody |